MedTrace Logo

Connect Lung Outcomes With Bronchodilator Use

NCT04417842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-04-27

No results posted yet for this study

Summary

To determine the accuracy of the Respimetrix flow-volume monitoring device in measuring the patient's inspiratory capacity as compared to gold-standard measurements of inspiratory capacity on pulmonary function testing. Accuracy will be assessed before and after (A) pulmonary function testing and before and after (B) the administration of an inhaled bronchodilator medication.

Conditions

Interventions

DIAGNOSTIC_TEST

Respimetrix flow-volume monitoring device

The Respimetrix flow-volume monitoring device is being tested to validate its ability to measure Inspiratory Capacity

Sponsors & Collaborators

  • Pulmonary Critical Care Associates of Baltimore

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-27
Primary Completion
2022-04-25
Completion
2022-04-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417842 on ClinicalTrials.gov